Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Pediatric Dermatology Morbidity and Mortality
Description
The presentation discusses two pediatric dermatology cases highlighting complications and treatment strategies. The first case involves a 14-year-old girl with linear IGA bullous disease and a history of paraspinal sarcoma, who struggled with high-dose prednisone and associated side effects. Treatment included the gradual introduction of dapsone, which led to complications such as methemoglobinemia. Adjustments in her treatment plan ultimately included intravenous immunoglobulin (IVIG), resulting in significant improvement and stabilization of her condition over time. The second case highlights a 9-year-old girl diagnosed with rhinoderma due to severe vitamin A deficiency from a restrictive diet. After recognizing her limited food intake and addressing the deficiencies through nutritional intervention and acquiring oral vitamin formulations that she would accept, her skin condition improved dramatically. Both cases emphasize the importance of thorough diagnostic work and a flexible treatment approach tailored to pediatric patients, leading to successful outcomes and resolution of complex dermatologic issues.
View moreConclusions
- Dapsone is an effective treatment for linear IgA bullous disease, but careful monitoring is essential due to potential complications.
- Methemoglobinemia is a significant risk in patients taking dapsone, particularly in those with renal issues or when exposed to certain anesthetics.
- Early identification and management of dietary deficiencies can lead to significant improvements in pediatric patients with dermatological conditions.
- Clinical vigilance for malnutrition is critical, even in children who appear otherwise healthy, as restrictive eating can complicate dermatological conditions.
- Alternative therapies such as IVIG can be beneficial when first-line treatments fail.
- Egan CA, Zone JJ. Int J Dermatol. 1999 Nov;38(11):818-827.
- Provost TT et al. Arch Dermatol. 1979 Feb;115(2):156-160.
- Wojnarowska F. J Roy Soc Med. 1980;73(5):371-373.
- Long SA et al. Arch Dermatol. 1988 Nov;124(11):1705, 1708.
- Patricio P et al. Ann N Y Acad Sci. 2009 Sep;1173:203-210.
- Piette EW, Werth VP. Dapsone in the management of autoimmune bullous diseases. Allergy Clin North Am. 2012 May;32(2):317-22.